Medicare Enrolled
Dr. Nirav Patel, M.D.
Neurology · Los Alamitos, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Nirav Patel is a neurology specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 13,927 Medicare services across 1,240 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $789,568 from 71 pharmaceutical and/or device companies across 1520 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$789,568 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,927
Medicare services
Top 8% in CA for neurology
1,240
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~733 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11,975 | $5 | $12 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
733 | $101 | $226 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $104 | $240 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
222 | $139 | $322 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
184 | $68 | $158 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
165 | $143 | $440 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
80 | $49 | $119 |
| New patient office visit, complex (60-74 min) | 52 | $182 | $456 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
36 | $125 | $318 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
31 | $175 | $602 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $80 | $163 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $146 | $363 |
| Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | 19 | $67 | $216 |
| Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 12 | $112 | $294 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$789,568
Total received (2018-2024)
Avg $112,795/year across 7 years
Top 1% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,520
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$744,419 (94.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$26,671 (3.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,478 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$109,242
2023
$139,710
2022
$124,134
2021
$121,112
2020
$85,645
2019
$144,161
2018
$65,564
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$89,264
Lundbeck LLC
$14,189
iSchemaView, Inc.
$3,543
Novartis Pharmaceuticals Corporation
$433
ABBVIE INC.
$313
UCB, Inc.
$235
Neurocrine Biosciences, Inc.
$191
PFIZER INC.
$160
Alexion Pharmaceuticals, Inc.
$157
Lilly USA, LLC
$120
SK Life Science, Inc.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$76
Celgene Corporation
$71
LivaNova USA, Inc.
$56
ARGENX US, INC.
$45
Biogen, Inc.
$40
Eisai Inc.
$36
Amylyx Pharmaceuticals, Inc.
$34
Neurelis, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
ACADIA Pharmaceuticals Inc
$25
TG Therapeutics, Inc.
$24
Merck Sharp & Dohme LLC
$21
Boston Scientific Corporation
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
SPR Therapeutics, Inc
$11
Top 3 companies account for 97.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$280,785
PORTOLA PHARMACEUTICALS, INC.
$163,771
Lilly USA, LLC
$121,549
Lundbeck LLC
$46,526
Alexion Pharmaceuticals, Inc.
$44,368
PORTOLA PHARMACEUTICALS, LLC
$32,384
AbbVie Inc.
$16,981
Allergan, Inc.
$15,514
Biogen, Inc.
$12,300
Eli Lilly and Company
$9,343
Biohaven Pharmaceutical Holding Company Ltd.
$7,141
Janssen Pharmaceuticals, Inc
$6,420
ABBVIE INC.
$6,072
Biohaven Pharmaceuticals, Inc.
$5,218
iSchemaView, Inc.
$4,680
Sage Therapeutics, Inc.
$2,931
Bayer Healthcare Pharmaceuticals Inc.
$2,081
Novartis Pharmaceuticals Corporation
$2,006
Janssen Research & Development, LLC
$1,054
Ipsen Pharma SAS
$874
Neurocrine Biosciences, Inc.
$713
Greenwich Biosciences, Inc.
$604
LivaNova USA, Inc.
$599
UCB, Inc.
$589
Genentech USA, Inc.
$512
Allergan Inc.
$445
SK Life Science, Inc.
$383
ARGENX US, INC.
$333
Jazz Pharmaceuticals Inc.
$308
PFIZER INC.
$271
Teva Pharmaceuticals USA, Inc.
$255
Celgene Corporation
$221
Amgen Inc.
$211
ACADIA Pharmaceuticals Inc
$188
Neurelis, Inc.
$175
Ipsen Biopharmaceuticals, Inc
$151
Eisai Inc.
$131
GENZYME CORPORATION
$103
MERZ NORTH AMERICA, INC.
$102
Takeda Pharmaceuticals U.S.A., Inc.
$99
Chiesi USA, Inc.
$90
Sunovion Pharmaceuticals Inc.
$84
Alnylam Pharmaceuticals Inc.
$69
NOVARTIS PHARMACEUTICALS CORPORATION
$66
Merz Pharmaceuticals, LLC
$65
Medtronic Vascular, Inc.
$63
Stryker Corporation
$53
Mitsubishi Tanabe Pharma America, Inc.
$51
EISAI INC.
$49
Genentech, Inc.
$48
Janssen Scientific Affairs, LLC
$48
AQUESTIVE THERAPEUTICS, INC.
$47
Harmony Biosciences LLC
$47
MITSUBISHI TANABE PHARMA AMERICA, INC.
$34
Amylyx Pharmaceuticals, Inc.
$34
Corium, LLC
$30
Kyowa Kirin, Inc.
$28
DePuy Synthes Sales Inc.
$25
Horizon Therapeutics plc
$24
Penumbra, Inc.
$24
TG Therapeutics, Inc.
$24
US WorldMeds, LLC
$22
Merck Sharp & Dohme LLC
$21
Upsher-Smith Laboratories LLC
$21
Mallinckrodt LLC
$18
Boston Scientific Corporation
$18
Microtransponder, Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
Amneal Pharmaceuticals LLC
$16
MDD US Operations, LLC
$15
SPR Therapeutics, Inc
$11
Top 3 companies account for 71.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · ARZERRA · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aduhelm · Aimovig · Andexxa · Artemis · Austedo XR · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CLEVIPREX · DUOPA · DYSPORT · Dysport · EMGALITY · EPIDIOLEX · EXPEDIUM · Epidiolex · Fycompa · GAMMAGARD · HYQVIA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQVIO · Leqembi · MAYZENT · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · RELYVRIO · REYVOW · RYTARY · Radicava · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRINT PNS System · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WELIREG · Wakix · XADAGO · XARELTO · XCOPRI · XEOMIN · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in CA.
Geographic Context
Neurologists within 10 mi
385
Per 100K population
12.2
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Patel performed 11,975 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $789,568 from 71 companies across 1,520 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in Los Alamitos?
Dr. Patel's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Los Alamitos
Browse neurologists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PORTOLA PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from PORTOLA PHARMACEUTICALS, INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology